Cargando…

Variation of glucose time in range in type 1 diabetes

INTRODUCTION: The aim of the study was to assess the variation of glucose time in range (TIR) for persons with type 1 diabetes who perform intermittently scanned continuous glucose monitoring (isCGM). METHODS: Glucose data for 8 weeks were analysed for 166 persons. TIR was calculated over four conse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Klavs Würgler, Bibby, Bo Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659659/ https://www.ncbi.nlm.nih.gov/pubmed/36172887 http://dx.doi.org/10.1002/edm2.379

Ejemplares similares

Effects of unrestricted access to flash glucose monitoring in type 1 diabetes
por: Hansen, Klavs Würgler
Publicado: (2020)

Effect of 12‐week continuous positive airway pressure therapy on glucose levels assessed by continuous glucose monitoring in people with type 2 diabetes and obstructive sleep apnoea; a randomized controlled trial
por: Banghøj, Anne Margareta, et al.
Publicado: (2020)

Determinants for adherence to continuous positive airway pressure therapy in obstructive sleep apnea
por: Jacobsen, Anne Roed, et al.
Publicado: (2017)

Time in Range Estimation in Patients with Type 2 Diabetes is Improved by Incorporating Fasting and Postprandial Glucose Levels
por: Sun, Rui, et al.
Publicado: (2023)

Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients
por: Wang, Yaxin, et al.
Publicado: (2022)

Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability
por: Klimontov, Vadim V., et al.
Publicado: (2023)

A Retrospective Study on the Time in Range of Blood Glucose and Type 2 Diabetic Peripheral Neuropathy
por: Li, Ming, et al.
Publicado: (2022)

Comment on: Hermida et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes. Diabetes Care 2011;34:1270–1276
por: Rossen, Niklas B., et al.
Publicado: (2011)

Determination of normal range for fasting salivary glucose in Type 1 diabetics
por: Arora, Karandeep Singh, et al.
Publicado: (2015)

Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
por: Murphy, Helen R.
Publicado: (2019)

Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes
por: Feng, Zhou-qin, et al.
Publicado: (2021)

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes
por: Bergenstal, Richard M., et al.
Publicado: (2023)

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
por: Mayeda, Laura, et al.
Publicado: (2020)

Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes
por: Guo, Qing-Yu, et al.
Publicado: (2020)

Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study
por: Laugesen, Esben, et al.
Publicado: (2013)

Circulating osteocalcin is associated with time in range and other metrics assessed by continuous glucose monitoring in type 2 diabetes
por: Liu, Jun, et al.
Publicado: (2022)

Protein intake during training sessions has no effect on performance and recovery during a strenuous training camp for elite cyclists
por: Hansen, Mette, et al.
Publicado: (2016)

Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy
por: Malecki, Maciej T., et al.
Publicado: (2020)

Time With Glucose Level in Target Range Among Children and Adolescents With Type 1 Diabetes After a Software Update to a Closed-Loop Glucose Control System
por: Marigliano, Marco, et al.
Publicado: (2022)

Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy
por: Yang, Junpeng, et al.
Publicado: (2020)

Time in range–A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study
por: Valenzano, Marina, et al.
Publicado: (2021)

Time in range and complications of diabetes: a cross-sectional analysis of patients with Type 1 diabetes
por: Bezerra, Marta Fernandes, et al.
Publicado: (2023)

Socioeconomic status and time in glucose target range in people with type 2 diabetes: a baseline analysis of the GP-OSMOTIC study
por: Tan, Mei Lyn, et al.
Publicado: (2018)

Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis
por: Stougaard, Elisabeth B, et al.
Publicado: (2022)

Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes
por: Irace, Concetta, et al.
Publicado: (2020)

Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range
por: Bailey, Timothy S., et al.
Publicado: (2023)

Preserved C-peptide secretion is associated with higher time in range (TIR) on intermittently scanned continuous glucose monitoring in Chinese adults with type 1 diabetes
por: Liu, Wei, et al.
Publicado: (2022)

Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study
por: Calhoun, Peter, et al.
Publicado: (2021)

Rethinking Carbohydrate Intake and Time in Range in Children and Adolescents with Type 1 Diabetes
por: Cherubini, Valentino, et al.
Publicado: (2021)

The Prognostic Value of Time in Range in Type 2 Diabetes
por: Selvin, Elizabeth
Publicado: (2021)

Relationship Between Time in Range and Dusk Phenomenon in Outpatients with Type 2 Diabetes Mellitus
por: Gao, Xiangyu, et al.
Publicado: (2023)

Time in Range in Children with Type 1 Diabetes before and during a Diabetes Camp—A Ceiling Effect?
por: Nagl, Katrin, et al.
Publicado: (2022)

Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
por: Gabbay, Monica Andrade Lima, et al.
Publicado: (2020)

Carbohydrate intake is associated with time spent in the euglycemic range in patients with type 1 diabetes
por: Ayano-Takahara, Shiho, et al.
Publicado: (2015)

Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review
por: Raj, Rishi, et al.
Publicado: (2022)

Letter to the Editor Regarding “Time in Range Estimation in Patients with Type 2 Diabetes is Improved by Incorporating Fasting and Postprandial Glucose Levels”
por: Aggarwal, Anshika, et al.
Publicado: (2023)

Time above range for predicting the development of type 2 diabetes
por: Marco, Alejandra, et al.
Publicado: (2022)

Predicting mammalian mutagenesis by submammalian assays: an application of database GEN.
por: Würgler, F E
Publicado: (1991)

Preimplantation Genetic Testing of Multiple Endocrine Neoplasia Type 2A
por: Würgler Hansen, Anders, et al.
Publicado: (2020)

Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes
por: Ruan, Yuting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2o3lnmccl71i6a95cuooi4thtn